Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring
Author(s) -
Wissam Kabbara,
Ghada El-Khoury,
Nour R Chamas
Publication year - 2018
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.9800
Subject(s) - vancomycin , medicine , therapeutic drug monitoring , dosing , trough level , therapeutic index , observational study , intensive care medicine , prospective cohort study , staphylococcus aureus , pharmacology , drug , pharmacokinetics , transplantation , tacrolimus , biology , bacteria , genetics
Vancomycin is the cornerstone of parenteral therapy for serious methicillin resistant Staphylococcus aureus infections. Optimal dosing of vancomycin is patient specific due to its narrow therapeutic window. The objective of this study is to evaluate the appropriate use of vancomycin focusing on the indication, dose, and therapeutic level monitoring.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom